By South SFV Today |
Aug 2, 2021
Stanford Medicine has recently become the first center in the United States to administer a new cell-based therapy, approved by the Food and Drug Administration (FDA), to a patient with metastatic melanoma. This innovative therapy, which provides hope for patients with advanced melanoma resistant to immunotherapies, is the first FDA-approved cell-based treatment for solid tumors.